Accelerate Diagnostics
AXDX
$5.25
Share price
-2.05%
Change (1 day)
191.66%
Change (1 year)
Categories
Revenue for Accelerate Diagnostics (AXDX)
Revenue in 2023 (TTM): $11.66 M
According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM) is $11.66 M. In 2022 the company made a revenue of $12.75 M an increase over the years 2021 revenue that were of $11.78 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Accelerate Diagnostics from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $11.66 M | -8.52% |
| 2022 | $12.75 M | 8.23% |
| 2021 | $11.78 M | 5.53% |
| 2020 | $11.16 M | 20.08% |
| 2019 | $9.29 M | 63.97% |
| 2018 | $5.67 M | 35.78% |
| 2017 | $4.17 M | 1597.56% |
| 2016 | $0.24 M | 67.35% |
| 2015 | $0.14 M | 20.49% |
| 2014 | $0.12 M | 152.67% |
| 2013 | $0.04 M | 14.16% |
| 2012 | $0.04 M | -95.06% |
| 2011 | $0.85 M | -68.22% |
| 2010 | $2.69 M | 173.81% |
| 2009 | $0.98 M | 38.39% |
| 2008 | $0.71 M | 271.6% |
| 2007 | $0.19 M | 4.91% |
| 2006 | $0.18 M | -67.85% |
| 2005 | $0.56 M | 3851.06% |
| 2004 | $0.01 M | -98.17% |
| 2003 | $0.78 M | 4.47% |
| 2002 | $0.75 M | 27.23% |
| 2001 | $0.59 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $43.52 B | 373,016.16% | 🇺🇸 USA |
 Becton Dickinson BDX | $19.04 B | 163,174.75% | 🇺🇸 USA |
 PerkinElmer
PKI | $3.35 B | 28,682.26% | 🇺🇸 USA |
 Bruker BRKR | $2.71 B | 23,170.47% | 🇺🇸 USA |
 NanoString Technologies NSTG | $0.14 B | 1,133.82% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $2.76 B | 23,638.04% | 🇺🇸 USA |